Image

Development of Upper Limb Motor Scale to Measure Quality of Movement and Body Awareness in Stroke

Recruiting
18 - 99 years of age
Both
Phase N/A

Powered by AI

Overview

For the breathing intervention, participants completed two experimental sessions at least two weeks apart. The experimental sessions were randomized between the slow-breathing condition (6 breaths/min) or the control breathing condition (12 breaths/min). Breathing interventions were 15 minutes in length and completed with the assistance of the breathing app, Breathe Deep (Mineev, Bizi Apps LLC).

The breathing intervention is currently completed.

The reliability and validity study of AFAS is ongoing. This is a one-time visit for participants in which participants will undergo screening of sensation and movement as well as fill in some questionnaires.

Description

All participants had two visits for the breathing exercise. The only planned intervention was the breathing exercise, which is now concluded.

The protocol for the breathing intervention was as follows: The breathing protocol lasted 15 minutes. It was a guided breathing awareness session with a registered nurse (PhD student) who is also trained in integrative therapies and yoga instruction.

In parallel, during one of the visits the reliability and validity of a new scale for stroke to measure quality of movement and body awareness is tested.

This part is still ongoing and thus this becomes a one-time visit.

Eligibility

Inclusion Criteria:

  • Females and males ages 18-99 years of age
  • People with stroke who are medically stable with one or more ischemic or
  • hemorrhagic stroke(s)
  • left or right hemiplegia
  • willing and able to attend a one-time behavioral testing session
  • willing and able to sign consent to participate
  • able to hear, read and comprehend instructions given during the study
  • English speaking (or willing to work with a (student) translator)

Exclusion Criteria:

  • cognitive impairment (Mini-mental State Exam-brief version, <13/16)
  • contractures in the tested arm that would hinder testing arm movements
  • adults lacking capacity to consent
  • severe neglect, aphasia, apraxia
  • other medical conditions that preclude participation

Study details

Stroke

NCT03328468

University of Minnesota

7 March 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.